Laboratory Compound Overview
Aromalyn 25mg Driada Medical is a pharmaceutical-grade exemestane formulation designed for advanced estrogen regulation research protocols. This aromatase inhibitor enables researchers to investigate complex hormonal pathways with precision and reliability. Each tablet delivers 25mg of active compound, meeting rigorous laboratory standards for consistency and purity. The formulation supports comprehensive endocrine research applications, particularly focusing on aromatase enzyme inhibition mechanisms. Research teams at Stroid UK Shop utilise this compound alongside other investigational materials from our extensive estrogen blocker research range to examine multifaceted hormonal interactions.
Scientific Research Applications
Researchers examine Aromalyn 25mg to study aromatase enzyme suppression mechanisms and downstream hormonal cascade effects. The compound facilitates investigation into estrogen biosynthesis pathways, enabling detailed analysis of enzymatic inhibition processes. Laboratory studies focus on understanding how exemestane irreversibly binds to aromatase enzymes, creating permanent inactivation suitable for extended research protocols. Scientists investigate dose-response relationships, examining varying concentrations to establish optimal research parameters. The formulation supports comparative studies with other research compounds from our SARM research collection and peptide research range, enabling comprehensive hormonal modulation research. Advanced protocols examine temporal effects, tissue-specific responses, and molecular-level interactions within controlled laboratory conditions.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Exemestane |
| Strength | 25mg per tablet |
| Manufacturer | Driada Medical |
| Form | Oral tablets |
| CAS Number | 107868-30-4 |
| Molecular Formula | C20H24O2 |
| Storage | Room temperature, dry conditions |
| Research Applications | Aromatase inhibition studies |
Laboratory Compliance Statement
Aromalyn 25mg Driada Medical is manufactured exclusively for in-vitro research applications and laboratory investigation purposes only. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory protocols, safety measures, and regulatory compliance when handling this material. All studies should be conducted under proper scientific supervision with adequate safety documentation and waste disposal procedures.
